Literature DB >> 14305376

CHEMOPROPHYLAXIS OF HOMOZYGOUS SICKLERS WITH ANTIMALARIALS AND LONG-ACTING PENICILLIN.

M A WARLEY, P J HAMILTON, P D MARSDEN, R E BROWN, J G MERSELIS, N WILKS.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ANEMIA, SICKLE CELL; CHILD; CHLOROQUINE; CLINICAL RESEARCH; DELAYED-ACTION PREPARATIONS; DRUG THERAPY; FINGERS; INFANT; INFLAMMATION; MALARIA; PENICILLIN G, BENZATHINE; PLACEBOS; PREVENTIVE MEDICINE; RESPIRATORY TRACT INFECTIONS; STATISTICS; TOES; UGANDA

Mesh：

Substances：

Year:  1965        PMID： 14305376      PMCID： PMC1845333          DOI： 10.1136/bmj.2.5453.86

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  PLASMODIUM MALARIAE IN UGANDAN CHILDREN. I. PREVALENCE IN YOUNG CHILDREN IN RURAL COMMUNITIES.

Authors:  E F JELLIFFE; D B JELLIFFE
Journal:  Am J Trop Med Hyg       Date:  1963-05       Impact factor: 2.345

2.  EFFECT OF PYREXIA ON SICKLAEMIC STATES.

Authors:  A K BASU; A W WOODRUFF
Journal:  Lancet       Date:  1963-11-23       Impact factor: 79.321

3.  A study of the survival rate of cases of sickle-cell anaemia.

Authors:  G F JACOB
Journal:  Br Med J       Date:  1957-03-30

4.  The natural history of homozygous sickle-cell anaemia in Central Africa.

Authors:  H C TROWELL; A B RAPER; H F WELBOURN
Journal:  Q J Med       Date:  1957-10

5.  A trial of chemoprophylaxis in sicklecell anaemia. Preliminary communication.

Authors:  C J LEWTHWAITE
Journal:  East Afr Med J       Date:  1962-05

6.  PLASMODIUM MALARIAE IN UGANDAN CHILDREN. II. MALARIA PARASITES IN CHILDREN AT MULAGO HOSPITAL IN KAMPALA.

Authors:  D L PRICE; C J LEWTHWAITE
Journal:  Am J Trop Med Hyg       Date:  1963-05       Impact factor: 2.345
  6 in total
  5 in total

Review 1.  Malaria chemoprophylaxis in sickle cell disease.

Authors:  O Oniyangi; A A A Omari
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

2.  The lung in sickle cell disease: a clinical overview of common vascular, infectious, and other problems.

Authors:  R C Young; O Castro; R P Baxter; R Dunn; E M Armstrong; F J Cook; C C Sampson
Journal:  J Natl Med Assoc       Date:  1981-01       Impact factor: 1.798

3.  A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease.

Authors:  Rasaq Olaosebikan; Kolade Ernest; Kalifa Bojang; Olugbenga Mokuolu; Andrea M Rehman; Muna Affara; Davis Nwakanma; Jean-René Kiechel; Taofik Ogunkunle; Tope Olagunju; Rukayat Murtala; Peter Omefe; Tosin Lambe; Surajudeen Bello; Olayinka Ibrahim; Benedict Olorunsola; Ayotade Ojuawo; Brian Greenwood; Paul Milligan
Journal:  J Infect Dis       Date:  2015-02-20       Impact factor: 5.226

4.  Safety and effectiveness of antimalarial therapy in sickle cell disease: a systematic review and network meta-analysis.

Authors:  Augustina Frimpong; Laty Gaye Thiam; Benjamin Arko-Boham; Ewurama Dedea Ampadu Owusu; George O Adjei
Journal:  BMC Infect Dis       Date:  2018-12-12       Impact factor: 3.090

5.  Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial.

Authors:  Victoria Nakibuuka; Grace Ndeezi; Deborah Nakiboneka; Christopher M Ndugwa; James K Tumwine
Journal:  Malar J       Date:  2009-10-24       Impact factor: 2.979
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.